<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Rev Bras Ter Intensiva</journal-id>
      <journal-id journal-id-type="iso-abbrev">Rev Bras Ter Intensiva</journal-id>
      <journal-title-group>
        <journal-title>Revista Brasileira de Terapia Intensiva</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0103-507X</issn>
      <issn pub-type="epub">1982-4335</issn>
      <publisher>
        <publisher-name>Associa&#xE7;&#xE3;o Brasileira de Medicina
intensiva</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25909317</article-id>
      <article-id pub-id-type="pmc">4396901</article-id>
      <article-id pub-id-type="doi">10.5935/0103-507X.20150013</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Recurrent rhabdomyolysis secondary to hyponatremia in a patient with
primary psychogenic polydipsia</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Rabdomi&#xF3;lise recorrente secund&#xE1;ria &#xE0; hiponatremia
em doente com polidipsia psicog&#xEA;nica prim&#xE1;ria</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Aguiar</surname>
            <given-names>Diana Tavares</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Monteiro</surname>
            <given-names>Catarina</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Coutinho</surname>
            <given-names>Paula</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <aff id="aff01"><label>1</label>Servi&#xE7;o de Medicina Interna, Hospital Geral, Centro Hospitalar
e Universit&#xE1;rio de Coimbra - Coimbra, Portugal.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01"><bold>Corresponding author:</bold> Diana Tavares Aguiar,
Servi&#xE7;o de Medicina Interna do Hospital Geral Centro Hospitalar e
Universit&#xE1;rio de Coimbra, Quinta dos Vales, S. Martinho do Bispo, 3041-801 -
Coimbra, Portugal. E-mail: <email>diana.t.aguiar@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jan-Mar</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jan-Mar</season>
        <year>2015</year>
      </pub-date>
      <volume>27</volume>
      <issue>1</issue>
      <fpage>77</fpage>
      <lpage>81</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>9</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>06</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Rhabdomyolysis is characterized by the destruction of skeletal muscle tissue, and its
main causes are trauma, toxic substances and electrolyte disturbances. Among the
latter is hyponatremia-induced rhabdomyolysis, a rare condition that occurs mainly in
patients with psychogenic polydipsia. Psycogenic polydipsia mostly affects patients
with schizophrenia, coursing with hyponatremia in almost 25% of the cases. It is also
in this context that rhabdomyolysis secondary to hyponatremia occurs most often. In
this article, the case of a 49-year-old male with a history of schizophrenia,
medicated with clozapine, and brought to the emergency room in a state of coma and
seizures is described. Severe hypoosmolar hyponatremia with cerebral edema was found
on a computed tomography examination, and a subsequent diagnosis of hyponatremia
secondary to psychogenic polydipsia was made. Hyponatremia correction therapy was
started, and the patient was admitted to the intensive care unit. After the
hyponatremia correction, the patient presented with analytical worsening, showing
marked rhabdomyolysis with a creatine phosphokinase level of 44.058UI/L on day 3 of
hospitalization. The condition showed a subsequent progressive improvement with
therapy, with no occurrence of kidney damage. This case stresses the need for
monitoring rhabdomyolysis markers in severe hyponatremia, illustrating the condition
of rhabdomyolysis secondary to hyponatremia induced by psychogenic polydipsia, which
should be considered in patients undergoing treatment with neuroleptics.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>A rabdomi&#xF3;lise &#xE9; caracterizada por destrui&#xE7;&#xE3;o de tecido
muscular esquel&#xE9;tico, sendo as suas principais causas o trauma, os
t&#xF3;xicos e os dist&#xFA;rbios hidroeletrol&#xED;ticos. Entre esses
&#xFA;ltimos, inclui-se a rabdomi&#xF3;lise induzida por hiponatremia, uma
situa&#xE7;&#xE3;o rara, que ocorre principalmente em doentes com polidipsia
psicog&#xEA;nica. Esta acomete maioritariamente doentes com esquizofrenia, cursando
com hiponatremia em quase 25% dos casos. &#xC9; tamb&#xE9;m nesse contexto que a
rabdomi&#xF3;lise secund&#xE1;ria a hiponatremia ocorre mais frequentemente.
Neste artigo, descreveu-se o caso de um homem de 49 anos, com antecedentes de
esquizofrenia, medicado com clozapina, trazido ao servi&#xE7;o de urg&#xEA;ncia
por quadro de coma e convuls&#xF5;es. Foi objetivada hiponatremia hiposmolar grave,
com edema cerebral em tomografia computorizada, sendo feito posteriormente o
diagn&#xF3;stico de hiponatremia secund&#xE1;ria &#xE0; polidipsia
psicog&#xEA;nica. Foi iniciada terap&#xEA;utica de corre&#xE7;&#xE3;o de
hiponatremia e internado em unidade de terapia intensiva. Feita
corre&#xE7;&#xE3;o de hiponatremia, contudo apresentou analiticamente marcada
rabdomi&#xF3;lise, de agravamento crescente, com creatinofosfoquinase de 44.058UI/L
no 3&#xBA; dia de interna&#xE7;&#xE3;o. Houve posterior redu&#xE7;&#xE3;o
progressiva com a terap&#xEA;utica, sem ocorr&#xEA;ncia de les&#xE3;o renal.
Este caso alerta para a necessidade de monitoriza&#xE7;&#xE3;o dos marcadores de
rabdomi&#xF3;lise na hiponatremia grave, ilustrando um quadro de
rabdomi&#xF3;lise secund&#xE1;ria &#xE0; hiponatremia induzida por polidipsia
psicog&#xEA;nica, situa&#xE7;&#xE3;o a considerar em doentes sob
terap&#xEA;utica com neurol&#xE9;pticos.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Polydipsia, psychogenic</kwd>
        <kwd>Water intoxication</kwd>
        <kwd>Hyponatremia</kwd>
        <kwd>Rhabdomyolysis</kwd>
        <kwd>Clozapine</kwd>
        <kwd>Myelinolysis, central pontine</kwd>
        <kwd>Case reports</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Rhabdomyolysis is a clinical entity characterized by the lysis of myocytes in the
skeletal muscle tissue and the release of their cell components, such as myoglobin, the
main cause of the toxic effects of rhabdomyolysis. The leading causes are trauma and
toxins (which include medications), but rhabdomyolysis can also occur due to electrolyte
disturbances, and the most often involved ion is potassium.<sup>(<xref rid="r01" ref-type="bibr">1</xref>)</sup></p>
      <p>The first rhabdomyolysis case associated with hyponatremia was described in 1979 by
Peter Browne, and since then, several cases have been documented; nonetheless, it has
remained a relatively rare disease. Some of the factors contributing for the occurrence
of this clinical condition are psychogenic polydipsia (PP), certain drug therapies
(thiazides and proton pump inhibitors), endocrine disorders (thyroid or adrenal disease)
and iatrogeny (particularly after prostate surgery or preparation for colonoscopy with
mannitol).<sup>(<xref rid="r02" ref-type="bibr">2</xref>)</sup></p>
      <p>PP often occurs in patients with psychiatric disorders, especially schizophrenia, and
hyponatremia occurs in 25% of the cases.<sup>(<xref rid="r02" ref-type="bibr">2</xref>)</sup> It is also in this clinical context that most cases of
rhabdomyolysis associated with hyponatremia occur. In this same patient group, rare
cases of rhabdomyolysis associated with hyponatremia correction are described in the
literature - most of these patients under psychiatric therapy (antipsychotic or
selective serotonin reuptake inhibitors - SSRIs).</p>
      <p>The authors describe here the case of a patient with hebephrenic schizophrenia admitted
to the intensive care unit for severe hyponatremia associated with marked
rhabdomyolysis, which was the second episode in the patient.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 49-year-old male with a history of schizophrenia, treated with clozapine and
risperidone, was brought to the emergency room in a coma (Glasgow coma scale 7 - E2M4V1)
with generalized tonic-clonic seizures. Tracheal intubation and mechanical ventilation
were performed, and the seizures were controlled with phenytoin perfusion. After initial
stabilization of the patient, further diagnostic tests were performed, which revealed
hypoosmolar hyponatremia (sodium 110mEq/L and osmolarity 220mOsm/L) and increased
creatine phosphokinase (CPK; 2.356UI/L) without other significant alterations. A
craniocerebral computed tomography scan was performed, which showed slight to moderate
cerebral edema. Given the severe and symptomatic hyponatremia, correction was initiated
with 3% sodium chloride, and the patient was admitted to the intensive care unit. At the
first ionic re-evaluation, a higher than expected increase in sodium was observed
(increase of 10 mEq in 6 hours); therefore, the sodium correction was suspended, and
close monitoring of natremia was maintained. In the first 12 hours after admission, the
patient experienced an increase of 15mEq, with natremia normalization on the third
hospitalization day, approximately 48 hours after admission. At that point, the
craniocerebral computed tomography was repeated, which showed clear improvement of the
cerebral edema. From a neurological point of view, sedation suspension was possible
approximately 24 hours after its introduction, with recovery of consciousness and no
associated neurological deficits, excluding the hypothesis of osmotic demyelination
syndrome. However, a progressive worsening of the rhabdomyolysis present at admission
was observed, occurring more acutely on the 3<sup>rd</sup> day of hospitalization with a
maximum CPK value of 44,065UI/L. The analytical progression of the patient is shown in
<xref ref-type="table" rid="t01">table 1</xref>.</p>
      <table-wrap id="t01" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Progression of analytical parameters during hospitalization</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="2" colspan="1">&#xA0;</th>
              <th align="center" rowspan="1" colspan="1">
                <bold>0 h</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>12 h</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>36 h</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>60 h</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>84 h</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>106 h</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>132 h</bold>
              </th>
            </tr>
            <tr>
              <th align="center" rowspan="1" colspan="1">
                <bold>(D1)</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>(D1)</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>(D2)</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>(D3)</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>(D4)</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>(D5)</bold>
              </th>
              <th align="center" rowspan="1" colspan="1">
                <bold>(D6)</bold>
              </th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Sodium (mmol/L)</td>
              <td align="center" rowspan="1" colspan="1">110</td>
              <td align="center" rowspan="1" colspan="1">125</td>
              <td align="center" rowspan="1" colspan="1">130.9</td>
              <td align="center" rowspan="1" colspan="1">137.4</td>
              <td align="center" rowspan="1" colspan="1">138.6</td>
              <td align="center" rowspan="1" colspan="1">139.9</td>
              <td align="center" rowspan="1" colspan="1">137.8</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">CPK (UI/L)</td>
              <td align="center" rowspan="1" colspan="1">2,356</td>
              <td align="center" rowspan="1" colspan="1">3,441</td>
              <td align="center" rowspan="1" colspan="1">9,470</td>
              <td align="center" rowspan="1" colspan="1">44,058</td>
              <td align="center" rowspan="1" colspan="1">14,930</td>
              <td align="center" rowspan="1" colspan="1">5,766</td>
              <td align="center" rowspan="1" colspan="1">759</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Urea (mmol/L)</td>
              <td align="center" rowspan="1" colspan="1">-</td>
              <td align="center" rowspan="1" colspan="1">3.1</td>
              <td align="center" rowspan="1" colspan="1">4.2</td>
              <td align="center" rowspan="1" colspan="1">4.0</td>
              <td align="center" rowspan="1" colspan="1">5.6</td>
              <td align="center" rowspan="1" colspan="1">5.7</td>
              <td align="center" rowspan="1" colspan="1">5.0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Creatinine (&#x3BC;mol/L)</td>
              <td align="center" rowspan="1" colspan="1">-</td>
              <td align="center" rowspan="1" colspan="1">74.3</td>
              <td align="center" rowspan="1" colspan="1">78.9</td>
              <td align="center" rowspan="1" colspan="1">48.9</td>
              <td align="center" rowspan="1" colspan="1">62.9</td>
              <td align="center" rowspan="1" colspan="1">75.2</td>
              <td align="center" rowspan="1" colspan="1">56.7</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">GOT/GPT (UI/L)</td>
              <td align="center" rowspan="1" colspan="1">-</td>
              <td align="center" rowspan="1" colspan="1">60/59</td>
              <td align="center" rowspan="1" colspan="1">72/46</td>
              <td align="center" rowspan="1" colspan="1">268/55</td>
              <td align="center" rowspan="1" colspan="1">155/40</td>
              <td align="center" rowspan="1" colspan="1">-</td>
              <td align="center" rowspan="1" colspan="1">43/38</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>h - hour; D - hospitalization day; CPK - creatine phosphokinase; GOT - glutamic
oxaloacetic transaminase; GPT - glutamic pyruvic transaminase.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>After ruling out neuroleptic malignant syndrome (apyrexia without autonomic dysfunction
or altered state of consciousness) and drug iatrogeny, fluid therapy was increased to
prevent nephropathy. The patient showed progressive improvement in the rhabdomyolysis
parameters with no acute kidney damage. After normalization of the rhabdomyolysis
parameters, risperidone (the previous medication) was introduced to the patient therapy
without a recurrence of rhabdomyolysis.</p>
      <p>The patient was discharged to psychiatric services on the 6<sup>th</sup> day of
hospitalization, and his routine therapy was changed (clozapine was suspended). He was
referred to a nursing facility due to the need for monitoring and surveillance. When
analyzing his personal history, a previous admission to the intensive care unit was
found for the same reason: severe hyponatremia in a PP context with rhabdomyolysis
complications, and at the time, he was also medicated with clozapine and
risperidone.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>PP is a disease that can be described as having three stages: the first stage is
polydipsia and polyuria, which evolves into hyponatremia in the second stage, and in the
third stage, it becomes &#x201C;water intoxication&#x201D;, a term first used in 1993, which can
manifest by worsening of psychiatric symptoms, nausea, vomiting, ataxia, delirium,
seizures or coma.<sup>(<xref rid="r02" ref-type="bibr">2</xref>)</sup></p>
      <p>This disease appears to be associated with certain individual characteristics, namely
male gender, chronic disease, heavy smoking, alcohol abuse and even certain psychiatric
illnesses, such as schizophrenia and cognitive deficits.<sup>(<xref rid="r03" ref-type="bibr">3</xref>)</sup></p>
      <p>Ingestion of large amounts of water alone does not induce hyponatremia; however, it may
occur in situations with a concurrent increase of antidiuretic hormone (ADH) secretion
or kidney damage. In fact, a 2001 study concluded that hyponatremia is more likely to
occur in patients with certain characteristics including comorbidities (such as kidney
failure), abnormal levels of potassium or certain therapeutics, such as diuretics,
calcium channel blockers and tricyclic antidepressants.<sup>(<xref rid="r04" ref-type="bibr">4</xref>)</sup> The administration of neuroleptics and SSRIs is equally
associated with more severe hyponatremia through mechanisms that are not yet fully known
but could be related to the activation of serotonin receptors (5-hydroxytryptamine-A2),
which result in increased cell permeability.<sup>(<xref rid="r04" ref-type="bibr">4</xref>)</sup></p>
      <p>Only approximately 17 to 25% of PP patients develop hyponatremia or water
intoxication.<sup>(<xref rid="r05" ref-type="bibr">5</xref>)</sup> As previously
mentioned, most PP cases occur in psychiatric patients, particularly schizophrenics,
which may be due to a greater sensitivity to ADH, changes in osmoregulatory mechanisms
or even increased ADH secretion.<sup>(<xref rid="r05" ref-type="bibr">5</xref>)</sup></p>
      <p>In the case described, the patient was treated with clozapine for several years without
evidence of rhabdomyolysis until the first hospitalization (6 months before the current
episode). In both hospital admissions, water intake in large amounts was reported (above
5L per day) in the days prior to hospital arrival. Similarly, in both cases, the patient
had severe symptomatic hyponatremia (seizures and coma) at admission. This patient
presented several risk factors classically associated with the development of
hyponatremia in PP, including an underlying disease (schizophrenia), male gender and
chronic use of atypical neuroleptics (clozapine).</p>
      <p>Since the first report of rhabdomyolysis associated with hyponatremia, these situations
have been described occasionally, with only small case series reporting this pathology.
This situation seems to be more common in patients under the effect of various
medications, especially thiazide diuretics, proton pump inhibitors and
trimethoprim-sulfamethoxazole.<sup>(<xref rid="r06" ref-type="bibr">6</xref>)</sup></p>
      <p>The mechanism by which hyponatremia induces rhabdomyolysis seems to be dysfunction of
the sodium/calcium pump, which leads to the activation of the proteases and lipases that
are responsible for cell lysis.<sup>(<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r06" ref-type="bibr">6</xref>)</sup> There is another theory arguing that the
decrease in the osmolarity of the extracellular fluid leads to the outflow of potassium
from the cells, resulting in its consequent depletion and cell destruction.<sup>(<xref rid="r07" ref-type="bibr">7</xref>)</sup> This last mechanism, reflecting the
inability of regulating cell volume, suggests an explanation for the occurrence of
rhabdomyolysis, both in hyponatremia and in its correction, which is another situation
that has been recently identified. It also justifies the importance of speed in
hyponatremia correction in the clinical condition of rhabdomyolysis, as shown by a study
by Morita et al.; the only factors directly associated with rhabdomyolysis in
hyponatremia were the rate of sodium correction per hour and an increase in the amount
of sodium in the first 24 hours. Several other factors were evaluated, and no
relationship seemed to exist among them (age, gender, previous alcohol consumption,
psychotropic drug overdose, Glasgow score, initial sodium, potassium, chloride or
glucose levels, plasma osmolarity and seizures as the initial manifestation).<sup>(<xref rid="r08" ref-type="bibr">8</xref>)</sup> Nevertheless, the risk of rapid
correction of hyponatremia is lower than the risk caused by a delay in the correction of
symptomatic hyponatremia. Hyponatremia guidelines have been recently revised, and an
increase of 5mEq in the first hour is currently recommended. Through the use of
hypertonic saline (3% NaCl) and subsequently normal saline (0.9% NaCl), a target of
10mEq in the first 24 hours can be reached, and thereafter, the goal is 8mEq/L per
day.<sup>(<xref rid="r09" ref-type="bibr">9</xref>)</sup> Higher corrections
increase the risk of pontine myelinolysis, which can lead to death.</p>
      <p>In the case described, the identified rhabdomyolysis presented several possible
etiologies. It is not always easy to distinguish the causes of rhabdomyolysis,
especially in cases that include hyponatremia (or its correction), seizures or
neuroleptics. However, the time profile, peak CPK elevation and clinical condition can
facilitate the etiological diagnosis. With regard to generalized tonic-clonic seizures
or the epileptic illness states (the condition presented by the patient at the initial
phase), the CPK increase starts at 3 hours and has a maximum peak classically described
between 18 and 24<sup>(<xref rid="r10" ref-type="bibr">10</xref>)</sup> and 36 and 40
hours,<sup>(<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r12" ref-type="bibr">12</xref>)</sup> with CPK increasing 8 to 12 times.<sup>(<xref rid="r13" ref-type="bibr">13</xref>)</sup> Higher values are reached in specific
clinical situations, such as trauma, prolonged surgeries with associated
ischemia,<sup>(<xref rid="r14" ref-type="bibr">14</xref>)</sup> and toxins and
drugs,<sup>(<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>)</sup> in addition to rhabdomyolysis caused by ionic or toxic
disorders.<sup>(<xref rid="r17" ref-type="bibr">17</xref>)</sup> In rhabdomyolysis
due to hyponatremia, the peak is reached at 48 to 96 hours, very often with values
between 18,000 - 98,000UI/L, and in rhabdomyolysis due to hyponatremia correction, the
peak is further delayed and often reached after 96 hours.<sup>(<xref rid="r17" ref-type="bibr">17</xref>)</sup> Rhabdomyolysis secondary to direct toxic effects of
neuroleptics on myocytes may arise after a few administrations or up to two years after
the beginning of medication administration.<sup>(<xref rid="r18" ref-type="bibr">18</xref>)</sup> In the case described, the patient had been medicated for over 5
years with clozapine without having ever presented rhabdomyolysis, which works against
this hypothesis. Although it is not possible to exclude the important role of the
seizures in this case, the late peak (between the 3<sup>rd</sup> and 4<sup>th</sup> day
of hospitalization - 48 and 60 hours) with an extremely high amount of CPK (more than
200 times the upper limit of normality) highly suggested that hyponatremia was the main
cause of rhabdomyolysis, possibly aggravated by its rapid correction.</p>
      <p>Recurrence of rhabdomyolysis due to hyponatremia is very uncommon and has been described
in the literature, to the best of the authors&#x2019; knowledge, in only three articles. In the
case described, the patient was admitted to the intensive care unit for the second time
for severe hyponatremia secondary to PP, leading to rhabdomyolysis, and the patient was
treated with neuroleptics (clozapine) in both hospitalizations. This is a classically
described added risk factor, which is why neuroleptic treatment was suspended in the
current hospitalization.</p>
      <p>The treatments of rhabdomyolysis and hyponatremia by PP are in direct contrast; in fact,
rhabdomyolysis must be treated with fluid therapy and eventual alkaline diuresis, while
symptomatic hyponatremia requires, in most cases, fluid restriction and 3% sodium
chloride. An interesting finding is the occurrence of a lower percentage of acute kidney
damage in rhabdomyolysis due to hyponatremia secondary to PP than rhabdomyolysis due to
other causes, leading some authors to propose the hypothesis of a possible
&#x201C;hypervolemia&#x201D; protective effect.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>CONCLUSION</title>
      <p>This article stresses the importance of frequent monitoring of muscle enzymes in
hyponatremia and its correction to quickly identify hyponatremia related rhabdomyolysis,
provide appropriate treatment and avoid complications.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p><bold>Conflicts of interest:</bold> None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>Responsible editor:</bold> Fl&#xE1;via Ribeiro Machado</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Efstratiadis</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Voulgaridou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nikiforou</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kyventidis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kourkouni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vergoulas</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyolysis updated</article-title>
          <source>Hippokratia</source>
          <year>2007</year>
          <volume>11</volume>
          <issue>3</issue>
          <fpage>129</fpage>
          <lpage>137</lpage>
          <pub-id pub-id-type="pmid">19582207</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Leon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Verghese</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tracy</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Josiassen</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Polydipsia and water intoxication in psychiatric patients: a review of
the epidemiological literature</article-title>
          <source>Biol Psychiatry</source>
          <year>1994</year>
          <volume>35</volume>
          <issue>6</issue>
          <fpage>408</fpage>
          <lpage>419</lpage>
          <pub-id pub-id-type="pmid">8018788</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonz&#xE1;lez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>P&#xE9;rez</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pe&#xF1;as-LLed&#xF3;</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>LLerena</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;lez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>de la Rubia</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>High risk of polydipsia and water intoxication in schizophrenia
patients</article-title>
          <source>Schizophr Res</source>
          <year>2008</year>
          <volume>99</volume>
          <issue>1-3</issue>
          <fpage>377</fpage>
          <lpage>378</lpage>
          <pub-id pub-id-type="pmid">17964118</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaidi</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyolysis after correction of hyponatremia in psychogenic
polydipsia possibly complicated by ziprasidone</article-title>
          <source>Ann Pharmacother</source>
          <year>2005</year>
          <volume>39</volume>
          <issue>10</issue>
          <fpage>1726</fpage>
          <lpage>1731</lpage>
          <pub-id pub-id-type="pmid">16131536</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ting</surname>
              <given-names>JY</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyolysis and polydipsic hyponatraemia</article-title>
          <source>Emerg Med J</source>
          <year>2001</year>
          <volume>18</volume>
          <issue>6</issue>
          <fpage>520</fpage>
          <pub-id pub-id-type="pmid">11696527</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Varghese</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Balakrishnan</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sadasivan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Narayanan</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
          <article-title>Muscle cell membrane damage by very low serum sodium</article-title>
          <source>Pan Afr Med J</source>
          <year>2009</year>
          <volume>3</volume>
          <fpage>14</fpage>
          <pub-id pub-id-type="pmid">21532723</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katsarou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Hyponatraemia associated rhabdomyolysis following water
intoxication</article-title>
          <source>BMJ Case Rep</source>
          <year>2010</year>
          <volume>2010</volume>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Inokuchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohama</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk factors for rhabdomyolysis in self-induced water intoxication
(SIWI) patients</article-title>
          <source>J Emerg Med</source>
          <year>2010</year>
          <volume>38</volume>
          <issue>3</issue>
          <fpage>293</fpage>
          <lpage>296</lpage>
          <pub-id pub-id-type="pmid">18439783</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spasovski</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Vanholder</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Allolio</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Annane</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ball</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bichet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Decaux</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fenske</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Hoorn</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Ichai</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Joannidis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Soupart</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zietse</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Haller</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>van der Veer</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Van Biesen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Nagler</surname>
              <given-names>E</given-names>
            </name>
            <collab>Hyponatraemia Guideline Development Group</collab>
          </person-group>
          <article-title>Clinical practice guideline on diagnosis and treatment of
hyponatraemia</article-title>
          <source>Eur J Endocrinol</source>
          <year>2014</year>
          <volume>170</volume>
          <issue>3</issue>
          <fpage>G1</fpage>
          <lpage>G47</lpage>
          <comment>Erratum in: Eur J Endocrinol. 2014;171(1):X1</comment>
          <pub-id pub-id-type="pmid">24569125</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Engel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pedley</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Aicardi</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <source>Epilepsy: a comprehensive textbook</source>
          <edition>2nd ed</edition>
          <publisher-loc>Philadelphiav</publisher-loc>
          <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
          <year>2008</year>
          <volume>3</volume>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brigo</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Igwe</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Erro</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bongiovanni</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Marangi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nardone</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Postictal serum creatine kinase for the differential diagnosis of
epileptic seizures and psychogenic non-epileptic seizures: a systematic
review</article-title>
          <source>J Neurol</source>
          <year>2014</year>
          <month>5</month>
          <day>14</day>
          <comment>[Epub ahead of print]</comment>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Moore</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <source>Textbook of clinical neuropsychiatry</source>
          <edition>2nd ed</edition>
          <publisher-loc>London</publisher-loc>
          <publisher-name>CRC Press</publisher-name>
          <year>2008</year>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Wildemann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Oschmann</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Reiber</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <source>Laboratory diagnosis in neurology</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Thieme</publisher-name>
          <year>2010</year>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Abdellati</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Eyselbergs</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sirimsi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hoof</surname>
              <given-names>VV</given-names>
            </name>
            <name>
              <surname>Wouters</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Verbrugghe</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>An observational study on rhabdomyolysis in the intensive care unit.
Exploring its risk factors and main complication: acute kidney
injury</article-title>
          <source>Ann Intensive Care</source>
          <year>2013</year>
          <volume>3</volume>
          <issue>1</issue>
          <fpage>8</fpage>
          <pub-id pub-id-type="pmid">23497406</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Veenstra</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Smit</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Krediet</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Arisz</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Relationship between elevated creatine phosphokinase and the clinical
spectrum of rhabdomyolysis</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>1994</year>
          <volume>9</volume>
          <issue>6</issue>
          <fpage>637</fpage>
          <lpage>641</lpage>
          <pub-id pub-id-type="pmid">7970089</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanekamp</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Zijlstra</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Tulleken</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Ligtenberg</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>van der Werf</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Hofstra</surname>
              <given-names>LS</given-names>
            </name>
          </person-group>
          <article-title>Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case
report</article-title>
          <source>Neth J Med</source>
          <year>2005</year>
          <volume>63</volume>
          <issue>8</issue>
          <fpage>316</fpage>
          <lpage>318</lpage>
          <pub-id pub-id-type="pmid">16186642</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menashe</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Borer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gilad</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Horowitz</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Rhabdomyolysis after correction of severe hyponatremia</article-title>
          <source>Am J Emerg Med</source>
          <year>2000</year>
          <volume>18</volume>
          <issue>8</issue>
          <fpage>229</fpage>
          <lpage>230</lpage>
          <pub-id pub-id-type="pmid">10750940</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aggarwal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Guanci</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Marambage</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Caplan</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>A patient with multiple episodes of rhabdomyolysis induced by
different neuroleptics</article-title>
          <source>Psychosomatics</source>
          <year>2014</year>
          <volume>55</volume>
          <issue>4</issue>
          <fpage>404</fpage>
          <lpage>408</lpage>
          <pub-id pub-id-type="pmid">24016383</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
